🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized controlled, phase III clinical trial. The...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2020-03-01
Trial ID
NCT03907826
Treatments Being Tested
This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-08-19
Trial ID
NCT04892043
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Status
Unknown
Location
Banner Health - MD Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03634332
Treatments Being Tested
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested